The Association between Proportion HLA-BW4 or HLA-BW6 May Causes Immunity Failure in COVID-19
Abstract
No AbstractÂ
1. Rahmani-Kukia N, Abbasi A. Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes. Frontiers in Endocrinology. 2021;12:84.
2. Rahmani-Kukia N, Abbasi A, Pakravan N, Hassan ZM. Measurement of oxidized albumin: An opportunity for diagnoses or treatment of COVID-19. Bioorganic Chemistry. 2020;105:104429.
3. Bernson E, Hallner A, Sander F, Wilsson O, Werlenius O, Rydström A, et al. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia. Leukemia. 2017;31(12):2552-9.
4. Wauquier N, Petitdemange C, Tarantino N, Maucourant C, Coomber M, Lungay V, et al. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection. EBioMedicine. 2019;40:605-13.
5. Lutz CT. HLA bw4 and bw6 epitopes recognized by antibodies and Natural Killer cells. Current opinion in organ transplantation. 2014;19(4):436.
6. Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, et al. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Human immunology. 2010;71(10):976-81.
7. Zhen JX, Cai SQ, Chen YT, Yang ZC, Zhuo JC, Deng ZH. KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han. BioMed Research International. 2020;2020.
8. Hollenbach JA, Pando MJ, Caillier SJ, Gourraud P-A, Oksenberg JR. The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans. Genes & Immunity. 2016;17(3):199-202
2. Rahmani-Kukia N, Abbasi A, Pakravan N, Hassan ZM. Measurement of oxidized albumin: An opportunity for diagnoses or treatment of COVID-19. Bioorganic Chemistry. 2020;105:104429.
3. Bernson E, Hallner A, Sander F, Wilsson O, Werlenius O, Rydström A, et al. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia. Leukemia. 2017;31(12):2552-9.
4. Wauquier N, Petitdemange C, Tarantino N, Maucourant C, Coomber M, Lungay V, et al. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection. EBioMedicine. 2019;40:605-13.
5. Lutz CT. HLA bw4 and bw6 epitopes recognized by antibodies and Natural Killer cells. Current opinion in organ transplantation. 2014;19(4):436.
6. Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, et al. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Human immunology. 2010;71(10):976-81.
7. Zhen JX, Cai SQ, Chen YT, Yang ZC, Zhuo JC, Deng ZH. KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han. BioMed Research International. 2020;2020.
8. Hollenbach JA, Pando MJ, Caillier SJ, Gourraud P-A, Oksenberg JR. The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans. Genes & Immunity. 2016;17(3):199-202
| Files | ||
| Issue | Vol 21 No 1 (2022) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijaai.v21i1.8625 | |
| Keywords | ||
| No Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Chegni H, Abbasi A, Rajayi H, Mohammad Hassan Z. The Association between Proportion HLA-BW4 or HLA-BW6 May Causes Immunity Failure in COVID-19. Iran J Allergy Asthma Immunol. 2022;21(1):101-103.
